{"id":692067,"date":"2022-10-04T16:11:29","date_gmt":"2022-10-04T20:11:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/"},"modified":"2022-10-04T16:11:29","modified_gmt":"2022-10-04T20:11:29","slug":"regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/","title":{"rendered":"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">TARRYTOWN, N.Y.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 4, 2022<\/span><\/span> \/PRNewswire\/ &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its third quarter 2022 financial and operating results on <span class=\"xn-chron\">Thursday, November 3, 2022<\/span>, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at <span class=\"xn-chron\">8:30 AM Eastern Time<\/span> that day.<\/p>\n<p>\n        <b>Conference Call Information\u00a0<br \/><\/b>Participants may access the conference call live via webcast on the &#8216;Investors and Media&#8217; page of Regeneron&#8217;s website at <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3665674-1&amp;h=1268386281&amp;u=https%3A%2F%2Finvestor.regeneron.com%2F&amp;a=https%3A%2F%2Finvestor.regeneron.com\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/investor.regeneron.com<\/a>. To participate via telephone, please register in advance at this <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3665674-1&amp;h=3083003620&amp;u=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBIb83feef4ba2e43e8aff1704dc1f6b2fb&amp;a=link\" target=\"_blank\" rel=\"nofollow noopener\">link<\/a><\/u>. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast will be archived on the Company&#8217;s website for at least 30 days.<\/p>\n<p>\n        <b>About<\/b>\u00a0<b>Regeneron<br \/><\/b>Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.<\/p>\n<p>Regeneron is accelerating and improving the traditional drug development process through our proprietary <i>VelociSuite\u00ae <\/i>technologies, such as <i>VelocImmune\u00ae<\/i>,\u00a0which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3665674-1&amp;h=445314063&amp;u=http%3A%2F%2Fwww.regeneron.com%2F&amp;a=www.Regeneron.com\" target=\"_blank\" rel=\"nofollow noopener\">www.Regeneron.com<\/a> or follow @Regeneron on Twitter.<\/p>\n<p>\n        <b>Contact Information:\u00a0<br \/><\/b>Investor Relations\u00a0<br \/><span class=\"xn-person\">Ryan Crowe<\/span><br \/>914.847.8790\u00a0<br \/><a href=\"mailto:ryan.crowe@regeneron.com\" target=\"_blank\" rel=\"nofollow noopener\">ryan.crowe@regeneron.com<\/a><\/p>\n<p>Corporate Communications <br \/><span class=\"xn-person\">Christina Chan<\/span><br \/>914.847.8827\u00a0<br \/><a href=\"mailto:christina.chan@regeneron.com\" target=\"_blank\" rel=\"nofollow noopener\">christina.chan@regeneron.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022-301640263.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022-301640263.html<\/a><\/p>\n<p>SOURCE  Regeneron Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY90986&amp;Transmission_Id=202210041600PR_NEWS_USPR_____NY90986&amp;DateId=20221004\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire TARRYTOWN, N.Y. , Oct. 4, 2022 \/PRNewswire\/ &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its third quarter 2022 financial and operating results on Thursday, November 3, 2022, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information\u00a0Participants may access the conference call live via webcast on the &#8216;Investors and Media&#8217; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692067","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TARRYTOWN, N.Y. , Oct. 4, 2022 \/PRNewswire\/ &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its third quarter 2022 financial and operating results on Thursday, November 3, 2022, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information\u00a0Participants may access the conference call live via webcast on the &#8216;Investors and Media&#8217; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be &hellip; Continue reading &quot;Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-04T20:11:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022\",\"datePublished\":\"2022-10-04T20:11:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/\"},\"wordCount\":357,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY90986&amp;sd=2022-10-04\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/\",\"name\":\"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY90986&amp;sd=2022-10-04\",\"datePublished\":\"2022-10-04T20:11:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY90986&amp;sd=2022-10-04\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY90986&amp;sd=2022-10-04\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 - Market Newsdesk","og_description":"PR Newswire TARRYTOWN, N.Y. , Oct. 4, 2022 \/PRNewswire\/ &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its third quarter 2022 financial and operating results on Thursday, November 3, 2022, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call Information\u00a0Participants may access the conference call live via webcast on the &#8216;Investors and Media&#8217; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be &hellip; Continue reading \"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-04T20:11:29+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022","datePublished":"2022-10-04T20:11:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/"},"wordCount":357,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/","name":"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04","datePublished":"2022-10-04T20:11:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90986&amp;sd=2022-10-04"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-third-quarter-2022-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-3-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on November 3, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692067"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692067\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}